ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,313,714 | +142.6% | 209,177 | +110.7% | 0.08% | +150.0% |
| Q1 2024 | $6,725,001 | -37.6% | 99,262 | -38.0% | 0.03% | -43.3% |
| Q4 2023 | $10,779,368 | +39.9% | 160,050 | +40.6% | 0.06% | +27.7% |
| Q3 2023 | $7,707,145 | -1.9% | 113,809 | +3.7% | 0.05% | -4.1% |
| Q2 2023 | $7,855,595 | +15.9% | 109,761 | +12.4% | 0.05% | +19.5% |
| Q1 2023 | $6,775,249 | +11.5% | 97,612 | +8.9% | 0.04% | +24.2% |
| Q4 2022 | $6,076,100 | +38.9% | 89,618 | +12.3% | 0.03% | +50.0% |
| Q3 2022 | $4,376,000 | -6.7% | 79,791 | +12.4% | 0.02% | +10.0% |
| Q2 2022 | $4,691,000 | -7.7% | 71,002 | -7.3% | 0.02% | 0.0% |
| Q1 2022 | $5,081,000 | +19.7% | 76,586 | +5.1% | 0.02% | -20.0% |
| Q4 2021 | $4,246,000 | -32.2% | 72,892 | -30.1% | 0.02% | -26.5% |
| Q3 2021 | $6,260,000 | +14.4% | 104,233 | +14.1% | 0.03% | -2.9% |
| Q2 2021 | $5,471,000 | – | 91,336 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |